Bright Arhin

In-Process Quality Checks and Post-Market Surveillance of Artemether-Lumefantrine Fixed-dose Combination Tablets and Suspensions: Current Procedures, Successes, Advances, and Challenges

Daniel Gyamfi, Julius Caesar Mahama, Ahmed S.B.I Fawzy, Alfred Gyimah, Faridu Abdul-Wadudu, Nobert Mantu Kipo, Bright Arhin, Bless Hayford Addo, Simon Nyarko & Comfort Wetani Aseyuure · Journal of Advances in Medical and Pharmaceutical Sciences · 2024

In Southeast Asia and Sub-Saharan Africa, approximately 35% of antimalarial drugs are of substandard quality. Counterfeit and substandard medications constitute 10% of the global pharmaceutical trade. The World Health Organization (WHO) recommends artemether-lumefantrine (AL) as...